Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

China’s AffaMed, EverInsight to Merge

China’s AffaMed Therapeutics announced Oct. 14 that it was merging with EverInsight Therapeutics, also of China. The combined entity, which will retain the AffaMed name, will focus on development o...

BreakingGene TherapyMergersOphthalmicRetina
Gemini Gains Nasdaq Listing in $216 Million Merger Deal with FS Development

Cambridge, Massachusetts-based Gemini Therapeutics will merge with FS Development Corp. to create a Nasdaq-listed company focused on age-related macular degeneration, the companies reported Oct. 15...

Katena Acquires Micro-Select Instruments

Katena Products of Parsippany, New Jersey, announced Oct. 20 that it had acquired Micro-Select Instruments of St. Clair, Missouri. Micro-Select, founded in 2005, specializes in manufacturing high-p...

Zhaoke Licenses Nevakar’s Myopia Candidate in Asian Markets

Nevakar, of Bridgewater, New Jersey, announced Oct. 20 that Hong Kong’s Zhaoke Ophthalmology had licensed Nevakar’s NVK-002 for pediatric myopia in the Greater China market, South Korea, and Southe...

BreakingDry EyeOphthalmicPharmaRegulation
Medicom’s Evolve Intensive Gel for Dry Eye Wins Approval in Canada

Medicom Healthcare, of the UK, and its partner Aequus Pharmaceuticals, of Canada, announced Oct. 19 that Aequus had secured approval in Canada for Evolve Intensive Gel—a crosslinked combination of ...

BreakingCataractClinical TrialOphthalmicSurgical
Positive Phase III Results for Sun Pharma Drop for Post-op Inflammation, Pain

Indian company Sun Pharma announced Oct. 14 that it saw positive topline results from its Phase III trial of SDN-037 for the treatment of inflammation and pain associated with ocular surgery. The p...

BreakingFundingGene TherapyOphthalmicRetina
French Gene Therapy Company SparingVision Raises $52.8 Million, Appoints New CEO

French gene therapy company SparingVision announced Oct. 21 that it had raised €44.5 million (US $52.8 million) in its latest financing round. The round was led by 4BIO Capital and UPMC Enterprises...

BreakingDry EyeFundingOphthalmic
Azura Raises $20 Million to Advance its Candidate for MGD

Azura Ophthalmics announced Oct. 22 that it had completed a $20 million financing round, led by existing investors including OrbiMed, TPG Biotech, Brandon Capital’s Medical Research Commercializati...

Join Market Scope Today

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

United States
US Surveys
May select more than one

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2020 Market Scope, LLC. All Rights reserved.